The therapeutic potential of endothelial progenitor cells in ischaemic stroke;Potencial terapéutico de las células progenitoras endoteliales en el ictus isquémico

Revista de Neurologia

Volumn 45, Issue 9, 2007, Pages 556-562

  Navarro, M ^a   Rosell, A ^a   Hernandez Guillamon M ^a   Cuadrado, E ^a   Montaner, Joan ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Vall Hebron Institut de Recerca   (Spain)

Author keywords

Angiogenesis; Brain ischemia; Endothelial progenitor cells (EPCs); Stroke; Therapeutic potential; Vasculogenesis

Indexed keywords

ANGIOGENESIS; BLOOD; BRAIN ISCHEMIA; BRAIN TISSUE; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CEREBROVASCULAR ACCIDENT; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HEMATOPOIETIC CELL; NONHUMAN; PHENOTYPE; REVIEW; STEM CELL; TISSUE INJURY;

EID: 37349105357     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4509.2007475     Document Type: Review

References (54)

1. Rosell A, Montaner J, Álvarez-Sabín J. Implicación de la angiogénesis en la isquemia cerebral humana. Rev Neurol 2004; 38: 1076-82.
2. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-6.
3. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11: 73-91.
4. Asahara T, Murshara T, Sullivan A, Silver M, Zee R, Li T, et al. Isolation of putative progenitor endotelial cells for angiogenesis. Science 1997; 275: 964.
5. Kuprinsky J, Kaluza J, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994; 25: 1794-8.
6. Slevin M, Kuprinski J, Slowic A. Serial measurement of vascular endothelial growth factor and transforming growth factor in serum of patient with acute ischemic stroke. Stroke 2000; 31: 1863-70.
7. Scheufler KM, Drevs J, van Velthoven V, Reusch P, Kliscti J, Augustin HG, et al. Implications of vascular endothelial growth factor sFlt-1 and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. J Cereb Blood Flow Metab 2003; 23: 99-110.
8. Valable S, Montaner J, Bellail A, Berezowski V, Brillanlt J, Cecchelli R, et al. VEGF induced BBB permeability is associated with and MMP-9 activity increase in cerebral ischemia both effects decreased by Ang-1. J Cereb Blood Flow Metab 2005; 25: 1491-504.
9. Zhang ZG, Zhang L, Jian Q, Zhang R, Davies K, Powers C, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-38.
10. Hayashi T, Noshita N, Sugawara. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 2003; 23: 166-80.
11. Lin T, Kim GM, Chen JJ, Cheung WM, He YY, Hsu CY. Differential regulation of thrombospondin 1 and thrombospondin 2 after focal cerebral ischemia/reperfusion. Stroke 2003, 34: 177-86.
12. Manookitiwongsa PS, Jackson-Friedman C, Millán PJ, Schultz RL, Lyden PD. Angiogenesis after stroke is correlated with increase numbers of macrophages: the clean-up hypotesis. J Cereb Blood Flow Metab 2001; 21: 1223-31.
13. Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, et al. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 2002; 22: 379-92.
14. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111: 1843-51.
15. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, et al. Therapeutic potential of ex vivo expanded endotelial progenitor cells for myocardium ischemia. Circulation 2001; 103: 634-7.
16. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.
17. Strauer B, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg R, et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-8.
18. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-7.
19. Tateishi-Yayuma E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-35.
20. Yamamoto K, Kondo T, Suzuki S, Izama H, Kobayashi M, Emi Nobuhiko, et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs. Arterioscler Thromb Vasc Biol 2004; 24: 192-6.
21. Hur J, Yoon CH, Kim HS, Choi JH, Khang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004; 24: 288-93.
22. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005; 112: 1618-27.
23. Ingram D, Mead L, Tanaka H, Meade V, Fenoglio A, Mortell K, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2753-60.
24. Ingram D, Caplice N, Yoder M. Unresolved questions, changing definition, and a novel paradigms for defining endothelial progenitor cells. Blood 2005; 106: 1525-31.
25. Yoder M, Mead L, Prater D, Krier T, Mroueh N, Li F. Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cells principals. Blood 2006; 419: 439-73.
26. Lin Y, Weisdorf D, Solovey A, Hebbel R. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-7.
27. Gulati R, Jevremovic D, Peterson T, Chattejee S, Shah V, Vile R, et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003; 93: 1023-5.
28. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiber AM, Dimmer S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003; 108; 2511-6.
29. Fuchs S, Hermanns M, Kirkpatrick Ch. Retention of differentiated endothelial phentotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures. Cell Tissue Res 2006; 326: 79-92.
30. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-53.
31. Bellik L, Ledda F, Parenti A. Morphological and phenotypical characterization of human endothelial progenitor cells in an early stage of differentiation. FEBS Lett 2005; 2731-6.
32. Sharpe E, Teleron A, Li B, Price J, Sands M, Alford K. The origin an in vivo significance of murine and human culture-expanded endothelial progenitor cells. Am J Pathol 2006; 168: 1710-21.
33. Gehling U, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-5112.
34. Rustemeyer P, Wittkowski W, Kershin J, Koller A. Optimitzed flow cytometria analysis of endothelial progenitor cells in peripheral blood. J Immunoassay Immunochem 2006; 27: 77-88.
35. Shaffer R, Greene S, Arshi A, Supple G, Bantly A, Moore JS. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom 2006; 70: 56-62.
36. Khan S, Solomon M, Mc Coy J. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005; 64: 1-8.
37. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004; 35: 2378-84.
38. Gulati R, Jevremovi D, Witt T, Kleppe L, Vile R, Lerman A. Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells. Am J Physiol Heart Cir Physiol 2004; 287: 512-7.
39. Hess D, Hill W, Martin-Studdard A, Carrol J, Brailer J, Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 2002; 22: 1362-8.
40. Zhang Z, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 2002; 90: 284-8.
41. Ohta T, Kikuta K, Imamura H, Takagi Y, Nishimura M, Masaki N, et al. Administration of ex vivo-expanded bone marrow-derived endotelial progenitor cells attenuates focal cerebral ischemia-reperfusion injury in rats. Neurosurgery 2006; 59: 679-86.
42. Shyu WC, Lin SZ, Chiang MF, Su CY, Li H. Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci 2006; 26: 3444-53.
43. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109: 2972-5.
44. Ghani U, Shnaib A, Salam A, Nasir A, Shnaib U, Jeeradathi T. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36: 151-3.
45. Sobrino T, Hurtado O, Moro MA, Rodríguez-Yáñez M, Castellanos M, Brea D, et al. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007; 38: 2759-64.
46. Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A, et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
47. Güven H, Shepherd R, Bach R, Capoccia B, Link D. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006; 48: 1579-87.
48. Sharp A, Zipori D, Toledo J, Tal S, Resnitzky P, Globerson A. Age related changes in hemopoietic capacity of bone marrow cells. Mech Ageing Dev 1989; 48: 91-9.
49. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006; 187: 423-32.
50. Delva P, Degan M, Vallerio P, Arosio E, Minuz P, Amen G, et al. Endothelial progenitor cells in patients with essential hypertension. J Hypertens 2007; 25: 127-32.
51. Fadini GP, Sartore S, Agostini C, Avogaro A. Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 2007; 30: 1305-13.
52. Werner N, Nickenig G. Endothelial progenitor cells in health and atherosclerotic disease. Ann Med 2007; 39: 82-90.
53. Walter DH, Dimmeler S, Zeiher AM. Effects of statins on endothelium and endothelial progenitor cell recruitment. Semin Vasc Med 2004; 4: 385-93.
54. Wang CH, Ting MK, Verma S, Kuo LT, Yang NI, Hsieh IC, et al. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am Heart J 2006; 152: 1051.